Key market opportunities include the rising prevalence of chronic diseases and increased regulatory approvals driving demand ...
Based on Ajinomoto Group’s collaborative development with Forge Biologics, now available worldwide Incheon, Korea — December 2025 — Ajinomoto CELLiST Korea, a subsidiary of the Ajinomoto Group ...
The FDA suspends Regenxbio gene therapy trials for Hurler and Hunter syndromes over safety concerns after a participant ...
New, well-characterized AAV reference standards enable accurate measurement of full and empty capsids, improving assay ...
Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the U.S. Food and Drug ...
An AAV vector genome integration event associated with PLAG1 overexpression was identified in a preliminary analysis of the resected tumor.
A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are encapsulated into recombinant adeno-associated virus (rAAV) capsids as ...
(Yicai) Jan. 28 -- Chinese medical researchers have made a breakthrough in gene therapy that overcomes the limitations of ...
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results